Emily Belowich supports clients across the healthcare system seeking to optimize payment and care-delivery strategies as they adapt their business models toward value-based environments.
She applies her background in quality improvement to support clients in work involving patient engagement, digital health, and strategic planning.
Prior to joining Avalere, Emily was a research consultant with The Lewin Group, where she collaborated with clinicians, administrators, quality improvement advisers, and patients to design and implement a national practice transformation program aimed at supporting clinicians in entering advanced payment models.
Emily has a BA from the Health: Science, Society, and Policy program at Brandeis University.
Authored Content
Stakeholders are contending with a new rule implementing stricter requirements on mental health care parity to ensure patient coverage and enhance equity.
Ahead of the American Society of Nephrology Kidney Week, Avalere experts dive into the key regulatory and legislative developments related to kidney disease that expect to see action in the remaining weeks of 2024.
Adequately treating mental health disorders can cut overall costs, including those from comorbidities, despite access barriers and high comorbidity expenses.
Innovation models will prioritize improving quality and redefine how quality is measured.
A dynamic regulatory landscape, technological advancements, and investments in R&D offer new opportunities and challenges in kidney care.
An analysis presented at ASN’s Kidney Week 2023 found lower rates of home dialysis utilization among Medicare dual eligibles compared to non-dual eligibles.
New analysis finds that just over 40,000 Medicare FFS patients with end-stage renal disease (ESRD) elected to enroll in Medicare Advantage during the 2021 open enrollment period—the first time all ESRD patients had access to an MA plan. This enrollment shift increased the proportion of ESRD patients enrolled in MA from 23% to 30%.
Longstanding barriers have limited rates of kidney transplantation, but recent changes in the policy landscape may signal changes for patients and providers.
The TDAPA supports payment and patient access to new therapies introduced to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS). CMS has continued to refine the payment designation through rulemaking. Stakeholders should continue to monitor this payment-adjustment policy, as it has evolved since its introduction and may continue to change in future rulemaking cycles.
Avalere experts discuss trends and advancements in the kidney disease space, including payment models, digital health interventions, and key considerations for manufacturers.
Continued shifts in Medicare Advantage enrollment introduce new value-based care opportunities for patients with ESRD.
Telehealth solutions aimed at enhancing quality, cost, and equity require greater investment in evidence generation and clinical practice guideline development.
The Health Systems Transformation Research Coordinating Center aims to change how research is generated, funded, and used to transform health systems in promotion of broader health equity for Medicaid-eligible individuals.
On November 4, Avalere presented a poster on disparities in wait times for kidney transplants at the American Society of Nephrology (ASN) Kidney Week 2022 conference.
The ESRD QIP is the first pay-for-performance program that penalizes dialysis facilities for not meeting performance thresholds.
Recent Medicare rulemaking requested stakeholder feedback on potential payment system changes to support access to therapies for patients on dialysis.
Tune into the third episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In the final segment, our Market Access and Policy experts take a deeper dive into disparities in kidney care and discuss how various groups are looking to address these gaps.
Tune into the third episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In the final segment, our Market Access and Policy experts take a deeper dive into disparities in kidney care and discuss how various groups are looking to address these gaps.
Tune into the second episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In this segment, our Market Access and Policy experts take a deeper dive into several of the policy and payment trends in the kidney disease space.
Tune into the second episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In this segment, our Market Access and Policy experts take a deeper dive into several of the policy and payment trends in the kidney disease space.
Tune into the first episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In this segment, our Market Access experts discuss the kidney disease patient population as well as treatment and payment systems this space.
Tune into the first episode in the Avalere Health Essential Voice podcast miniseries focused on the evolving kidney care landscape. In this segment, our Market Access experts discuss the kidney disease patient population as well as treatment and payment systems this space.
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.
On December 14, 2020, an intensive care unit nurse in New York was the first American to receive an injection of the COVID-19 vaccine.
Avalere conducted a national survey of more than 200 independent primary care providers concerning the impacts of the COVID-19 pandemic on their ability to support continued vaccination programs for patients. Over 90% of respondents indicated the COVID-19 pandemic has increased operating costs and led to revenue loss. Eighty-two percent indicated that an increase in vaccine administration fees would aid sites in overcoming barriers arising from the COVID-19 pandemic, and 75% expressed interest in implementing new care delivery arrangements to facilitate immunizations during the COVID-19 pandemic.
As businesses across the country begin to reopen, navigating the COVID-19 pandemic will continually require employers to be resilient, flexible, innovative, and forward looking when it comes to returning employees safely to work sites. Among the myriad of concerns and considerations, organizational leadership will need tools that assist decision making and ensure compliance with Centers for Disease Control and Prevention (CDC) guidance.
Rising healthcare costs and the increased prevalence of chronic disease in the US are incentivizing stakeholders to develop new solutions to tackle these issues. Many have turned to digital health innovations like mobile health applications to facilitate care prevention and management for chronic disease, but significant gaps remain in their ability to be used in real-world practice.
Tune in to hear the final episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 3, we’ll be focusing on the End Stage Renal Disease (ESRD) Prospective Payment System, with a focus on proposed payment changes for innovative drugs, supplies, and equipment and updates to the Quality Incentive Program (QIP).
It is no surprise that innovation in the world of digital health is transforming the way healthcare is delivered.
The Centers for Medicare & Medicaid Services (CMS) is embracing digital health and virtual care in many ways.
In early February, Avalere attended the annual Centers for Medicare & Medicaid Services (CMS) Quality Conference, an annual gathering that brings stakeholders together to address challenges in healthcare quality improvement and discuss ways to spread these solutions locally and nationally.